A comparative study of amyloid fibril formation by residues 15-19 of the human calcitonin hormone: a single beta-sheet model with a small hydrophobic core.

Experimentally, the human calcitonin hormone (hCT) can form highly stable amyloid protofibrils. Further, a peptide consisting of hCT residues 15-19, DFNKF, was shown to create highly ordered fibrils, similar to those formed by the entire hormone sequence. However, there are limited experimental data regarding the detailed 3D arrangement of either of these fibrils. We have modeled the DFNKF protofibril, using molecular dynamics simulations. We tested the stabilities of single sheet and of various multi sheet models. Remarkably, our most ordered and stable model consists of a parallel-stranded, single beta-sheet with a relatively insignificant hydrophobic core. We investigate the chemical and physical interactions responsible for the high structural organization of this single beta-sheet amyloid fibril. We observe that the most important chemical interactions contributing to the stability of the DFNKF organization are electrostatic, specifically between the Lys and the C terminus, between the Asp and N terminus, and a hydrogen bond network between the Asn side-chains of adjacent strands. Additionally, we observe hydrophobic and aromatic pi stacking interactions. We further simulated truncated filaments, FNKF and DFNK. Our tetra-peptide mutant simulations assume models similar to the penta-peptide. Experimentally, the FNKF does not create fibrils while DFNK does, albeit short and less ordered than DFNKF. In the simulations, the FNKF system was less stable than the DFNK and DFNKF. DFNK also lost many of its original interactions becoming less organized, however, many contacts were maintained. Thus, our results emphasize the role played by specific amino acid interactions. To further study specific interactions, we have mutated the penta-peptide, simulating DANKF, DFNKA and EFNKF. Here we describe the model, its relationship to experiment and its implications to amyloid organization.

[1]  L. Serpell,et al.  Structure and texture of fibrous crystals formed by Alzheimer's abeta(11-25) peptide fragment. , 2003, Structure.

[2]  R. Nussinov,et al.  The sequence dependence of fiber organization. A comparative molecular dynamics study of the islet amyloid polypeptide segments 22-27 and 22-29. , 2003, Journal of molecular biology.

[3]  Christopher M Dobson,et al.  The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation , 2002, The EMBO journal.

[4]  A. Caflisch,et al.  The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Lansbury,et al.  Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.

[6]  A. Drake,et al.  The structure and mechanism of formation of human calcitonin fibrils. , 1993, The Journal of biological chemistry.

[7]  P. Selvin.  Lighting up single ion channels. , 2003, Biophysical journal.

[8]  C. Dobson.  Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[9]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[10]  D. Engelman,et al.  Design of single-layer β-sheets without a hydrophobic core , 2000, Nature.

[11]  C. Alemán,et al.  Binding in complex ionic systems: anticooperative effects in systems stabilized by electrostatic interactions , 2001 .

[12]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[13]  R. Tycko.  Insights into the amyloid folding problem from solid-state NMR. , 2003, Biochemistry.

[14]  C. Dobson.  Protein Folding and Disease: a view from the first Horizon Symposium , 2003, Nature Reviews Drug Discovery.

[15]  M. Zaidi,et al.  Forty years of calcitonin--where are we now? A tribute to the work of Iain Macintyre, FRS. , 2002, Bone.

[16]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[17]  Ehud Gazit,et al.  A possible role for π‐stacking in the self‐assembly of amyloid fibrils , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  D. Thirumalai,et al.  Dissecting the assembly of Abeta16-22 amyloid peptides into antiparallel beta sheets. , 2003, Structure.

[19]  R. Nussinov,et al.  The stability and dynamics of the human calcitonin amyloid peptide DFNKF. , 2004, Biophysical journal.

[20]  C. Alemán,et al.  A molecular dynamics study of the stoichiometric complex formed by poly (alpha, L-glutamate) and octyltrimethylammonium ions in chloroform solution. , 2002, Biopolymers.

[21]  R. Nussinov,et al.  Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ16–22, Aβ16–35, and Aβ10–35): Sequence effects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Nussinov,et al.  Molecular dynamics simulations of alanine rich β‐sheet oligomers: Insight into amyloid formation , 2002, Protein science : a publication of the Protein Society.

[23]  C. Blake,et al.  From the globular to the fibrous state: protein structure and structural conversion in amyloid formation , 1998, Quarterly Reviews of Biophysics.

[24]  R. Kisilevsky.  Review: amyloidogenesis-unquestioned answers and unanswered questions. , 2000, Journal of structural biology.

[25]  S Gnanakaran,et al.  Peptide folding simulations. , 2003, Current opinion in structural biology.

[26]  L. Serrano.  The relationship between sequence and structure in elementary folding units. , 2000, Advances in protein chemistry.

[27]  Ruth Nussinov,et al.  Peptide sequence and amyloid formation; molecular simulations and experimental study of a human islet amyloid polypeptide fragment and its analogs. , 2004, Structure.

[28]  N. Berger,et al.  Calcitonin-like immunoreactivity of amyloid fibrils in medullary thyroid carcinomas , 1988, Virchows Archiv A.

[29]  C. Dobson,et al.  High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[31]  E. Wanker.  Protein aggregation in Huntington's and Parkinson's disease: implications for therapy. , 2000, Molecular medicine today.

[32]  R. Nussinov,et al.  Short peptide amyloid organization: stabilities and conformations of the islet amyloid peptide NFGAIL. , 2003, Biophysical journal.

[33]  Meital Reches,et al.  Amyloid Fibril Formation by Pentapeptide and Tetrapeptide Fragments of Human Calcitonin* , 2002, The Journal of Biological Chemistry.

[34]  D. Thirumalai,et al.  Dissecting the assembly of A β 16-22 amyloid peptides into antiparallel β-sheets , 2002 .

[35]  M. Butler,et al.  Immunoreactive calcitonin in amyloid fibrils of medullary carcinoma of the thyroid gland. An immunogold staining technique. , 1986, Archives of Pathology & Laboratory Medicine.